Anelis Quintana Cantillo, MSc

Placeholder Person Graphic
Anelis Quintana Cantillo, MSc, holds a bachelor’s degree in biology and a master’s degree in drug technology and control, both from Havana University. Anelis currently works in the R&D BioProcess Development Department at the Center of Molecular Immunology in Havana. Anelis has expertise in mammalian cell culture and fermentation processes development, laboratory-scale purification of monoclonal antibodies, and quantification and analytical characterization of monoclonal antibodies by ELISA, weak cation exchange chromatography and gel filtration in HPLC, SDS-PAGE, western blot, etc.

Related Articles

Figure 4: SDS-PAGE under nonreduced conditions of the fi nal purified SP Sepharose Fast Flow.
Technical
Effects of Tank-Agitated Fermentation on Therapeutic mAb Quality

Regulatory authorities have approved the use of recombinant monoclonal antibodies (mAbs) to treat infectious diseases1  and chronic conditions such as cancer

  • 1Sparrow, E., M. Friede, M. Sheikh, and S. Torvaldsen. “Therapeutic Antibodies for Infectious Diseases.” Bulletin of the World Health Organization 95, no. 3 (2017):235–237. doi:10.2471/BLT.16.178061